Lu Kang Pharmaceutical announced on September 29 that Deputy General Manager Yang Sujuan stepped down that day and will no longer hold a position at the company. The company also appointed Liu Xuesong as Deputy General Manager. In the first half of 2026, Lu Kang Pharmaceutical achieved revenue of 3.238 billion yuan and net profit attributable to the parent of 138 million yuan.
Shandong Lukang Pharmaceutical Co LtdDeputy GM Yang Sujuan steps down and Liu Xuesong is appointed; a management change with no stated operational or financial driver.
